In certain circumstances, differences in prostate cancer treatment outcomes for Black men may not be due to biological differences in tumor aggressiveness, a Harvard Medical School and Brigham and Women’s Hospital in Boston found.
According to the study, led by Dr. Quoc-Dien Trinh, there are no overall or cancer-related race differential survival rates among the